PTP4A3 and neoplasm: The lack of correlation of anti-proliferative effects with PRL-3 expression we demonstrated in canine cancer cell lines does not rule out PRL-3 inhibition as a mechanism; it merely suggests that if this mechanism is functional in canine cells, PRL-3 may not play a role as an oncogenic driver in resistant cell and tumor models.